🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST

Edwards Lifesciences Stock Forecast

Stock Price Forecast

According to 30 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $113.83. The average 1-year stock price forecast is 11.76% higher than the current stock price, while the lowest is $84 (-17.53%) and the highest is $126 (+23.71%).

Price Target: $113.83 (+11.76%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$84$113.83$116$126
Change-17.53%+11.76%+13.89%+23.71%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy171818181820
Buy444455
Hold877774
Sell000001
Strong Sell000000
Total292929293030

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Reiterates
$115
BuyReiterates$115+12.91%Nov 20, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
$112 → $116
BuyReiterates$112 → $116+13.89%Nov 19, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$113 → $121
BuyReiterates$113 → $121+18.80%Nov 16, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 9, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$117 → $121
BuyReiterates$117 → $121+18.80%Nov 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.81B
from 6.07B
Increased by 12.24%
Revenue Next Year
7.48B
from 6.81B
Increased by 9.84%
EPS This Year
3.01
from 2.56
Increased by 17.74%
EPS Next Year
3.40
from 3.01
Increased by 12.95%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.23B4.46B5.01B5.44B6.07B6.81B
Revenue Growth
19.29%-14.69%12.23%8.57%11.55%12.24%
Gross Profit
3.98B3.74B4.03B4.32B4.73B5.33B
Gross Margin
76.13%83.82%80.47%79.46%78.01%78.23%
Operating Income
1.59B1.54B1.49B1.48B1.64B1.98B
Net Income
1.50B1.52B1.40B4.17B1.07B1.34B
EPS
----2.563.01
EPS Growth
----5.35%17.74%
Forward PE
52.9830.3528.4131.1930.9333.79
Free Cash Flow
----1.34B1.14B
No. Analysts
-----27
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.9B
Avg6.8B
Low6.7B

Revenue Growth

Revenue Growth202620272028
High
13.1%
Avg
12.2%
Low
10.8%

EPS Forecast

EPS202620272028
High3.05
Avg3.01
Low2.97

EPS Growth

EPS Growth202620272028
High
19.1%
Avg
17.7%
Low
16.0%